Healthcare entity
Of the tracked stories, 1 of 2 also mention 3M, the most common co-covered peer. The 26-day window averages about 0.5 stories each week. They are better corroborated than the beat average, carrying 10.5 original sources each against 3.1 for the same window.
Last mentioned: Mar 24, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 1 of 2 also mention 3M, the most common co-covered peer. The 26-day window averages about 0.5 stories each week. They are better corroborated than the beat average, carrying 10.5 original sources each against 3.1 for the same window. The clearest coverage concentration is market-trends: 1 of 2 stories, with the rest divided among 1 other category. Their average consequence score of 6 runs above the beat's 5.9 for that window. Solventum appears in 2 tracked Healthcare stories published from February 27, 2026 through March 24, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 510 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Solventum. Shared-story counts are live from our verified record — not editorial picks.
Solventum (SOLV) shares experienced a notable decline on Tuesday, reflecting investor concerns over the company's ability to maintain margins following its high-profile spin-off from 3M. The downward movement comes amid broader market volatility affecting growth-oriented healthcare technology and medical device firms.
The fourth quarter of 2025 revealed a decisive shift in the healthcare technology sector toward AI-integrated diagnostics and high-margin specialized therapies. Leading the charge, Butterfly Network reported record revenue growth driven by its AI-embedded strategy, while Solventum navigated its post-spin-off stabilization phase with resilient organic growth.
Solventum is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
